Prospective trial of vitamin D in MS


REPORT FROM THE 2009 AAN ANNUAL MEETING – High-dose vitamin D3 supplementation appears to be well tolerated and significantly reduces T cell reactivity, according to the results of a prospective Canadian trial (Burton et al. AAN 2009; abstract P01.110).


It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page